CE Credits Available for this Activity: .5
Release and Expiration Dates
11/8/2023 – 11/8/2026
Knowledge Gap: This activity aims to educate healthcare providers with the most up-to-date information on using quality design in clinical research trials.
Target Audience: The target audience includes all healthcare professionals such as physicians, nurses, pharmacists, and allied health professionals who would like to gain essential insights and practical strategies for designing successful clinical trials that are inclusive, community-focused, and scientifically robust.
Program Overview: The purpose of this activity is to educate medical professionals on using quality design in clinical research trials.
Objectives
Identify essential causes that can contribute to failed clinical trials.
Review best practices to ensure the recruitment of diverse and representative cohorts when designing clinical research.
Understand the critical role of community and patient perspective when designing clinical trials.
References
Nature | Vol 619 | 20 July 2023 |
The New York Times “F.D.A. Revokes Approval of Avastin for Use as Breast Cancer Drug”
By Andrew Pollack | 18 November 2011
The Society of Clinical Research Associates (SoCRA)
National Institute of Health (NIH) National Center for Advancing Translational Sciences
Clinical Trials Transformation Initiative (CTTI)
Financial Disclosure Statement
The following planners, speakers, moderators, peer reviewers, and/or panelists of this CE activity have financial relationships with ineligible companies to disclose:
Jessica Snowden, MD – Consultant: Pfizer
All financial relationships have been mitigated.
No other planners, speakers, and/or peer reviewers of this CME activity have relevant financial relationships with ineligible companies to disclose.
The compliance reviewer, Courtney Bryant, Sara Hale, or Brandie Jones, has no relevant financial relationships with ineligible companies to disclose.
Planners: Jessica Snowden, MD; Jeannette Lee, PhD; Lora Lawrence, RN; Catrice Banks-Johnson, MPA; DeAnn Hubberd, MA
Speaker(s): Dan Cooper, MD
Speaker(s) Bio
Dr. Dan Cooper is a Distinguished Professor of Pediatrics, interim Executive Director of the UC Irvine Institute for Precision Health, Associate Director of the UC Irvine Institute of Clinical and Translational Science (ICTS, UC Irvine’s NIH Clinical Translational Science Award), and Clinical Informatics and Analytics Unit Director of the UC Irvine Pediatric Exercise and Genomics Research Center. Dr. Cooper’s research seeks to understand the role of physical activity and exercise in the growth and development of children and adolescents in health and disease. Ongoing research areas include novel approaches to gas exchange signal transduction during exercise; genomic and epigenetic responses to exercise in circulating immune cells; rethinking protocols for exercise testing in children with a specific focus on children with sickle cell disease and children with cystic fibrosis, and the optimal use of school-based physical fitness testing to mitigate health care disparities.
Instructions to Obtain Credit
(1) Launch the activity
(2) View the module
(3) Take 1 post-test at the end
(4) Complete Evaluation and Print certificate
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the University of Arkansas for Medical Sciences. University of Arkansas for Medical Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statements
AMA Credit Designation Statement
The University of Arkansas for Medical Sciences designates this enduring material activity for a maximum of .5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACPE Credit Designation Statement
These knowledge-based activities will provide pharmacists with up to .5 contact hour or .5 CEU. CE credit information, based on participation and completion of the program evaluation, will be provided to NABP within 60 days after the activity completion.
ANCC Credit Designation Statement
The University of Arkansas for Medical Sciences designates this enduring material activity for a maximum of .5 ANCC contact hours. Nursing contact hours will be awarded for successful completion of program components based upon documented attendance and completion of evaluation materials.
AAPA Credit Designation Statement
The University of Arkansas for Medical Sciences has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Disclosure Policy Statement
It is the policy of the University of Arkansas for Medical Sciences (UAMS), Office of Continuing Education (OCE) to ensure balance, independence, objectivity, and scientific rigor in all directly or jointly provided educational activities. All individuals who are in a position to control the content of the educational activity (course/activity directors, planning committee members, staff, teachers, or authors of CE) must disclose all relevant financial relationships they have with any commercial interest(s) as well as the nature of the relationship. The ACCME describes relevant financial relationships as those in any amount occurring within the past 24 months that create a conflict of interest. Individuals who refuse to disclose will be disqualified from participation in the development, management, presentation, or evaluation of the CE activity.
UAMS Office of Continuing Education (OCE) Contact Information
Email: cmeconf@uams.edu
Phone: 501-661-7962
DCOC Contact Information
Catrice Banks-Johnson
Email: crbanksjohnson@uams.edu
DeAnn Hubberd
Email: DEHubberd@uams.edu
